Wellspring Biosciences Overview
- Year Founded
-
2012

- Status
-
Out of Business
- Employees
-
5

- Latest Deal Type
-
Out of Business
Wellspring Biosciences General Information
Description
Developer of small-molecule drugs designed for the treatment of cancer and other diseases. The company specializes in translating chemical and biological insights into novel, highly targeted drugs that are cell-active and mutant-specific, thereby enabling patients to have access to unique and potent drugs.
Contact Information
Website
www.wellspringbiosciences.comCorporate Office
- 3033 Science Park Drive
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 3033 Science Park Drive
- Suite 200
- San Diego, CA 92121
- United States
Wellspring Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Out of Business | 16-Dec-2024 | Completed | Out of Business | |||
4. Grant | 01-Jan-2014 | Completed | Startup | |||
3. Merger/Acquisition | 01-Jan-2013 | Completed | Startup | |||
2. Accelerator/Incubator | Completed | Startup | ||||
1. Early Stage VC (Series A) | Completed | Startup |
Wellspring Biosciences Comparisons
Industry
Financing
Details
Wellspring Biosciences Competitors (57)
One of Wellspring Biosciences’s 57 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
Macrogenics | Formerly VC-backed | Rockville, MD | ||||
Actinium Pharmaceuticals | Formerly VC-backed | New York, NY | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Pharmacyclics | Formerly VC-backed | Sunnyvale, CA |
Wellspring Biosciences Patents
Wellspring Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2019388998-A1 | Compounds and methods of use thereof for treatment of cancer | Inactive | 29-Nov-2018 | ||
CA-3120383-A1 | Compounds and methods of use thereof for treatment of cancer | Pending | 29-Nov-2018 | ||
EP-3887373-A1 | Compounds and methods of use thereof for treatment of cancer | Inactive | 29-Nov-2018 | ||
US-20220112192-A1 | Compounds and methods of use thereof for treatment of cancer | Inactive | 29-Nov-2018 | ||
AU-2019364417-A1 | 2-(2-acryloyl-2,6-diazaspiro[3.4]octan-6-yl)-6-(1h-indazol-4-yl)-benzonitrile derivatives and related compounds as inhibitors of g12c mutant kras protein for inhibiting tumor metastasis | Inactive | 24-Oct-2018 | C07D487/10 |
Wellspring Biosciences Signals
Wellspring Biosciences FAQs
-
When was Wellspring Biosciences founded?
Wellspring Biosciences was founded in 2012.
-
Where is Wellspring Biosciences headquartered?
Wellspring Biosciences is headquartered in San Diego, CA.
-
What is the size of Wellspring Biosciences?
Wellspring Biosciences has 5 total employees.
-
What industry is Wellspring Biosciences in?
Wellspring Biosciences’s primary industry is Drug Discovery.
-
Is Wellspring Biosciences a private or public company?
Wellspring Biosciences is a Private company.
-
What is Wellspring Biosciences’s current revenue?
The current revenue for Wellspring Biosciences is
. -
Who are Wellspring Biosciences’s competitors?
AnTolRx, Macrogenics, Actinium Pharmaceuticals, NexImmune, and Pharmacyclics are some of the 57 competitors of Wellspring Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »